The HeraBEAT foetal heart rate monitor. Source: HeraMED
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • HeraMED (HMD) partners with e-Lōvu Health to supply its HeraCARE remote pregnancy monitoring technology to customers in the United States
  • The companies strike a binding term sheet that will see the HeraMED supply 1000 kits to expectant mothers at e-Lōvu’ partner healthcare provider sites
  • During the first year, e-Lōvu will pay HeraMED about US$550,000 (A$787,000) for the technology and a HeraCARE license
  • The first e-Lōvu site is expected to launch by the end of the year, with full deployment expected in the next six to twelve months
  • Shares in HeraMED are up 25 per cent to 16 cents per share at 10:17 am AEST

Pregnancy care tech specialist HeraMED (HMD) has partnered with e-Lōvu Health to supply its HeraCARE remote pregnancy monitoring technology to customers in the United States.

The companies have signed a binding term sheet that will see HeraMED supply 1000 kits to expectant mothers at e-Lōvu’ partner healthcare provider sites.

The kits to be provided under the deal include the HeraBEAT foetal heart rate monitor and Bluetooth-connected blood pressure cuffs with HeraCARE connectivity, which allow future mothers to monitor their pregnancies.

During the first year of the deal, e-Lōvu will pay HeraMED about US$550,000 (A$787,000) for the technology and a HeraCARE license.

However, this is subject to e-Lōvu Health securing the required funding, which is expected at the end of the third quarter this year.

The first e-Lōvu site is expected to launch by the end of the year, with full deployment expected in the next six to twelve months.

Following the initial period, the companies plan to enter a long-term strategic partnership.

HeraMED CEO and Cofounder David Groberman said he saw great potential in the partnership.

“The deal clearly validates the advantages of our technology and business model and officially launches our commercialisation into the United States market,” Mr Groberman said.

Shares in HeraMED were up 25 per cent to 16 cents per share at 10:17 am AEST.

HMD by the numbers
More From The Market Herald
The Market Herald Video

" Caprice Resources (ASX:CRS) intersects shallow gold at Island Gold Project

Caprice Resources (ASX:CRS) intersects shallow gold mineralisation at its first reverse circulation drilling program at the…

" Orion Minerals (ASX:ORN) raises $1.35m in SPP

Orion Minerals (ASX:ORN) has raised $1.35 million in its share purchase plan (SPP) to advance its…

" Future Metals (ASX:FME) to raise $5.5m for Panton

Future Metals (ASX:FME) has received firm commitments for a heavily oversubscribed $5 million placement.

" Firebird Metals (ASX:FRB) raises $3.5m to accelerate Oakover development

Firebird Metals (ASX:FRB) has received firm commitments to raise $3.5 million via a placement from sophisticated…